L162-0607 Screening compound: N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide

L162-0607 Screening compound: N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide
L162-0607 Screening compound: N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L162-0607
N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L162-0607

Molecular Formula

C27H33N5O2 (C27 H33 N5 O2)

Compound Name

N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide

IUPAC name

N-[3-(morpholin-4-yl)propyl]-1-(4-phenylpiperazin-1-yl)isoquinoline-7-carboxamide

SMILES

O=C(c1cc2c(N(CC3)CCN3c3ccccc3)nccc2cc1)NCCCN1CCOCC1

InChI

InChI=1S/C27H33N5O2/c33-27(29-10-4-12-30-17-19-34-20-18-30)23-8-7-22-9-11-28-26(25(22)21-23)32-15-13-31(14-16-32)24-5-2-1-3-6-24/h1-3,5-9,11,21H,4,10,12-20H2,(H,29,33)

InChI Key

ZRQQWDGJMBQOAY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27235342

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.125

Distribution Coefficient, logD

2.737

Water Solubility, LogSw

-3.32

Polar Surface Area

51.806

Acid Dissociation Constant (pKa)

14.01

Base Dissociation Constant (pKb)

7.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.74

L162-0607 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

MCL1 Targeted Library (12200 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L162-0607 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L162-0607?
Check Price and Availability of L162-0607, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L162-0607 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L162-0607
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L162-0607
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L162-0607 available by request